Our results demonstrate that Prkci promotes CRC growth by stabilizing c-Myc through phosphorylation at serine 21, thereby enhancing c-Myc’s resistance to ubiquitin–proteasome-mediated degradation. Here, PRKCI is linked to colorectal carcinoma.